Novanta Inc (NOVT): Market Cap to Revenue

Symbol and logo of brand Novanta Inc (NOVT)

Geopolitical fragmentation is limiting exports of high-precision systems from Novanta Inc. (NOVT), which is reflected in the price-to-sales ratio dynamics. The value of 4.10 determines the latest valuation metric. Business stability is based on the supply of optics for surgical robotics and the deep integration of components into the supply chains of the largest medical conglomerates, which minimizes the risks of price wars.

NOVT Novanta Inc P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Novanta Corp (NOVT)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:NOVT novanta.com
Core merchandise of Novanta Inc.

Novanta Inc. combines a resilient healthcare sector with moderately cyclical supplies of industrial components and lasers. An analysis of the relationship between value and sales volumes allows for an assessment of market capitalization relative to actual revenues, determining whether current demand is fundamentally justified or speculative, which is critical for evaluating business sustainability during periods of macroeconomic recession.

Competitors of Novanta Inc.

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|HAE - Market Cap to Revenue|Inspire Sleep - P/S Multiple|Price to Sales Procept|CNMD: P/S Multiple|Market Cap to Revenue Ratio PLSE|INMD (InMode) - P/S Multiple|Picard Medical Corp (PMI) - Price-to-Revenue Coefficient|P/S Multiple SRDX|Market Cap to Revenue Eversense SENS|P/S Multiple NPCE (NeuroPace, Inc.)|P/S Multiple Tactile Systems Technology, Inc. TCMD|SNWV - Price-to-Revenue Ratio|OM: Price-to-Revenue Ratio|ELMD (smartvest.com) - Market Cap to Revenue|LENSAR Inc - Market Capitalization-to-Revenue Ratio|RCEL (AVITA Medical, Inc.) - P/S Multiple|Price to Sales Profound Medical Corporation PROF|Price-to-Revenue Ratio Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Price-to-Revenue Multiple|Apyx Medical Corporation - Market Cap to Revenue|P/S Multiple IceCure Medical Ltd. ICCM|Pulmonx Corp. - P/S Multiple|Price-to-Revenue Coefficient TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus Healthcare Inc)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue electroCore Medical (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|Profusa Inc (PFSA) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio SSKN|Price-to-Revenue Ratio GlucoTrack, Inc.|Price to Sales nanovibronix.com NAOV|Market Cap to Revenue VERO (Venus Concept Corp)|Price-to-Revenue Ratio NUWE (Nuwellis Corp)|P/S Multiple AEMD (Aethlon Medical)|P/S Multiple Asensus Surgical Inc ASXC|AVGR - Price-to-Revenue Ratio|BSGM (BioSig) - Market Cap to Revenue Ratio|CUTR (Cutera, Inc) - Market Cap to Revenue|KNW: Market Cap to Sales Volume|NARI (Inari Medical, Inc.) - P/S Multiple|P/S Multiple nevro.com|Market Cap to Revenue RSLS (ReShape Lifesciences)|SILK (Silk Road Medical, Inc.) - Market Capitalization-to-Revenue Ratio